Actelion awarded the Prix Hermès de l'Innovation
Advertisement
Actelion Ltd announced that the company will receive this year's Prix Hermès de l'Innovation in the category "amélioration de la condition humaine" (improvement in the conditions of human life).
The European Institute for Creative Strategies and Innovation awards the Prix Hermès annually to selected institutions and companies in recognition of their outstanding innovative achievements in different areas of life. It includes a total of eight different categories. The award ceremony will take place in Paris on April 19th.
Actelion receives the Prix Hermès for its extensive innovative research work for improving the quality of life of patients. In particular, the Prize recognizes Actelion's commitment to improve treatment of children with rare diseases, especially in pulmonary arterial hypertension.
Martine Clozel, Chief Scientific Officer of Actelion, said: "We are honored to be awarded this Prize, which acknowledges the commitment of Actelion to innovative research for the benefit of patients with rare diseases. In particular, it recognizes our efforts to help children. With Tracleer, we began developing a formulation adapted to children with pulmonary arterial hypertension particularly early in the development".
Most read news
Organizations
Other news from the department business & finance
Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.